{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:24:05Z","timestamp":1791685445887,"version":"4.3.4"},"reference-count":333,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004507","name":"Central Drug Research Institute","doi-asserted-by":"publisher","award":["10896"],"award-info":[{"award-number":["10896"]}],"id":[{"id":"10.13039\/501100004507","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Neuroscience"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.mcn.2024.103981","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:54:05Z","timestamp":1733446445000},"page":"103981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Glutathione S-transferase: A keystone in Parkinson's disease pathogenesis and therapy"],"prefix":"10.1016","volume":"132","author":[{"given":"Pratyush","family":"Padhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Simran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb0005","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1038\/s41598-022-07909-7","article-title":"An assessment of the rescue action of resveratrol in parkin loss of function-induced oxidative stress in Drosophila melanogaster","volume":"12","author":"Adedara","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mcn.2024.103981_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105874","article-title":"Implications of glial metabolic dysregulation in the pathophysiology of neurodegenerative diseases","volume":"174","author":"Afridi","year":"2022","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.mcn.2024.103981_bb0015","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bbadis.2016.11.005","article-title":"Nrf2 signaling pathway: pivotal roles in inflammation","volume":"1863","author":"Ahmed","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"5","key":"10.1016\/j.mcn.2024.103981_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/biom10050770","article-title":"Proeryptotic activity of 4-Hydroxynonenal: a new potential Physiopathological role for lipid peroxidation products","volume":"10","author":"Allegra","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.mcn.2024.103981_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2023.105949","article-title":"A scoping review on the diagnosis and treatment of X-linked dystonia-parkinsonism","volume":"119","author":"Alonto","year":"2024","journal-title":"Parkinsonism Relat. Disord."},{"issue":"4","key":"10.1016\/j.mcn.2024.103981_bb0030","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/FTD.0000000000000957","article-title":"Impact of glutathione S-transferase polymorphisms on Busulfan pharmacokinetics and outcomes of hematopoietic stem cell transplantation","volume":"44","author":"Al-Riyami","year":"2022","journal-title":"Ther. Drug Monit."},{"issue":"2","key":"10.1016\/j.mcn.2024.103981_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12020175","article-title":"Environmental impact on the epigenetic mechanisms underlying Parkinson\u2019s disease pathogenesis: a narrative review","volume":"12","author":"Angelopoulou","year":"2022","journal-title":"Brain Sci."},{"issue":"6","key":"10.1016\/j.mcn.2024.103981_bb0040","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1517\/17425255.2013.780027","article-title":"Utilization of glutathione S-transferase mu 1- and Theta 1-null mice as animal models for absorption, distribution, metabolism, excretion and toxicity studies","volume":"9","author":"Arakawa","year":"2013","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"6","key":"10.1016\/j.mcn.2024.103981_bb0045","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson disease: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb0050","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/tx960072x","article-title":"Structure, catalytic mechanism, and evolution of the glutathione transferases","volume":"10","author":"Armstrong","year":"1997","journal-title":"Chem. Res. Toxicol."},{"issue":"16","key":"10.1016\/j.mcn.2024.103981_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168689","article-title":"Glutathione and related molecules in parkinsonism","volume":"22","author":"Asanuma","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb0060","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrneurol.2014.226","article-title":"The ongoing pursuit of neuroprotective therapies in Parkinson disease","volume":"11","author":"Athauda","year":"2015","journal-title":"Nat. Rev. Neurol."},{"issue":"46","key":"10.1016\/j.mcn.2024.103981_bb0065","doi-asserted-by":"crossref","first-page":"11108","DOI":"10.1021\/bi901180v","article-title":"Glutathione transferases are structural and functional outliers in the thioredoxin fold","volume":"48","author":"Atkinson","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.mcn.2024.103981_bb0070","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fnagi.2020.00097","article-title":"Glucocerebrosidase defects as a major risk factor for Parkinson\u2019s disease","volume":"12","author":"Avenali","year":"2020","journal-title":"Front. Aging Neurosci."},{"issue":"38","key":"10.1016\/j.mcn.2024.103981_bb0075","doi-asserted-by":"crossref","first-page":"15259","DOI":"10.1073\/pnas.1305687110","article-title":"Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex","volume":"110","author":"Baird","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mcn.2024.103981_bb0080","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fneur.2019.00218","article-title":"Parkinson\u2019s disease and the environment","volume":"10","author":"Ball","year":"2019","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.mcn.2024.103981_bb0085","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/03602532.2011.558092","article-title":"Interactions of glutathione transferases with 4-hydroxynonenal","volume":"43","author":"Balogh","year":"2011","journal-title":"Drug Metab. Rev."},{"issue":"2","key":"10.1016\/j.mcn.2024.103981_bb0090","article-title":"Sulforaphane-a compound with potential health benefits for disease prevention and treatment: insights from pharmacological and toxicological experimental studies","volume":"13","author":"Baralic","year":"2024","journal-title":"Antioxidants (Basel)"},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb0095","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2174\/157015910790909485","article-title":"Cyclooxygenase and neuroinflammation in Parkinson\u2019s disease neurodegeneration","volume":"8","author":"Bartels","year":"2010","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.mcn.2024.103981_bb0100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jchromb.2016.02.002","article-title":"The functional interactome of GSTP: a regulatory biomolecular network at the interface with the Nrf2 adaption response to oxidative stress","volume":"1019","author":"Bartolini","year":"2016","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"issue":"Pt B","key":"10.1016\/j.mcn.2024.103981_bb0105","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.freeradbiomed.2015.06.039","article-title":"Glutathione S-transferase pi expression regulates the Nrf2-dependent response to hormetic diselenides","volume":"88","author":"Bartolini","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.mcn.2024.103981_bb0110","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10565-020-09517-5","article-title":"Glutathione S-transferase P influences the Nrf2-dependent response of cellular thiols to seleno-compounds","volume":"36","author":"Bartolini","year":"2020","journal-title":"Cell Biol. Toxicol."},{"issue":"5","key":"10.1016\/j.mcn.2024.103981_bb0115","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2217\/epi-2023-0428","article-title":"Unlocking the epigenetic symphony: histone acetylation's impact on neurobehavioral change in neurodegenerative disorders","volume":"16","author":"Basavarajappa","year":"2024","journal-title":"Epigenomics"},{"issue":"3","key":"10.1016\/j.mcn.2024.103981_bb0120","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00441-005-0150-8","article-title":"Expression patterns and novel splicing variants of glutathione-S-transferase isoenzymes of human lung and hepatocyte cell lines","volume":"324","author":"Bauer","year":"2006","journal-title":"Cell Tissue Res."},{"issue":"20","key":"10.1016\/j.mcn.2024.103981_bb0125","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1212\/WNL.0000000000003946","article-title":"Nrf2, cellular redox regulation, and neurologic implications","volume":"88","author":"Benarroch","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.mcn.2024.103981_bb0130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.mehy.2017.02.017","article-title":"Iron accumulation, glutathione depletion, and lipid peroxidation must occur simultaneously during ferroptosis and are mutually amplifying events","volume":"101","author":"Bertrand","year":"2017","journal-title":"Med. Hypotheses"},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb0135","doi-asserted-by":"crossref","first-page":"69","DOI":"10.7314\/APJCP.2012.13.1.069","article-title":"Polymorphic variation in glutathione-S-transferase genes and risk of chronic myeloid leukaemia in the Kashmiri population","volume":"13","author":"Bhat","year":"2012","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"3","key":"10.1016\/j.mcn.2024.103981_bb0140","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s10753-020-01202-3","article-title":"GSTP1 inhibits LPS-induced inflammatory response through regulating autophagy in THP-1 cells","volume":"43","author":"Bi","year":"2020","journal-title":"Inflammation"},{"issue":"4","key":"10.1016\/j.mcn.2024.103981_bb0145","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s11910-003-0008-y","article-title":"Surrogate endpoints in Parkinson\u2019s disease research","volume":"3","author":"Biglan","year":"2003","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"10","key":"10.1016\/j.mcn.2024.103981_bb0150","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1093\/brain\/awab191","article-title":"The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson's disease","volume":"144","author":"Biondetti","year":"2021","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.mcn.2024.103981_bb0155","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/alz.12387","article-title":"Unraveling the heterogeneity in Alzheimer\u2019s disease progression across multiple cohorts and the implications for data-driven disease modeling","volume":"18","author":"Birkenbihl","year":"2022","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010042","article-title":"Mediterranean diet and Parkinson\u2019s disease","volume":"24","author":"Bisaglia","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.mcn.2024.103981_bb0165","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.parkreldis.2011.09.019","article-title":"Role of glutathione S-transferase T1, M1 and P1 polymorphisms in Indian Parkinson\u2019s disease patients","volume":"18","author":"Biswas","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"issue":"2","key":"10.1016\/j.mcn.2024.103981_bb0170","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3109\/03602532.2011.561353","article-title":"The omega-class glutathione transferases: structure, function, and genetics","volume":"43","author":"Board","year":"2011","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.mcn.2024.103981_bb0175","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0076-6879(05)01004-9","article-title":"Human glutathione transferase zeta","volume":"401","author":"Board","year":"2005","journal-title":"Methods Enzymol."},{"issue":"5","key":"10.1016\/j.mcn.2024.103981_bb0180","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1016\/j.bbagen.2012.11.019","article-title":"Glutathione transferases, regulators of cellular metabolism and physiology","volume":"1830","author":"Board","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"32","key":"10.1016\/j.mcn.2024.103981_bb0185","doi-asserted-by":"crossref","first-page":"24798","DOI":"10.1074\/jbc.M001706200","article-title":"Identification, characterization, and crystal structure of the omega class glutathione transferases","volume":"275","author":"Board","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.mcn.2024.103981_bb0190","first-page":"381","article-title":"Sleep and Parkinson disease","volume":"114","author":"Bollu","year":"2017","journal-title":"Mo. Med."},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb0195","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3324\/haematol.2013.089888","article-title":"Glutathione transferase-A2 S112T polymorphism predicts survival, transplant-related mortality, busulfan and bilirubin blood levels after allogeneic stem cell transplantation","volume":"99","author":"Bonifazi","year":"2014","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.mcn.2024.103981_bb0200","first-page":"679","article-title":"Glutathione-S-transferase P1 isoenzyme polymorphisms, platinum-based chemotherapy, and non-small cell lung cancer","volume":"1","author":"Booton","year":"2006","journal-title":"J. Thorac. Oncol."},{"issue":"4","key":"10.1016\/j.mcn.2024.103981_bb0205","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/03602532.2012.713969","article-title":"Inhibition and induction of glutathione S-transferases by flavonoids: possible pharmacological and toxicological consequences","volume":"44","author":"Bousova","year":"2012","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.mcn.2024.103981_bb0210","article-title":"Pathoanatomy of Parkinson\u2019s disease","volume":"247 Suppl 2","author":"Braak","year":"2000","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.mcn.2024.103981_bb0215","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.yfrne.2008.02.001","article-title":"Progesterone receptors: form and function in brain","volume":"29","author":"Brinton","year":"2008","journal-title":"Front. Neuroendocrinol."},{"issue":"17","key":"10.1016\/j.mcn.2024.103981_bb0220","first-page":"3915","article-title":"Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk","volume":"56","author":"Brockmoller","year":"1996","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.mcn.2024.103981_bb0225","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1096\/fj.06-7426com","article-title":"Oxidative stress in Caenorhabditis elegans: protective effects of the omega class glutathione transferase (GSTO-1)","volume":"22","author":"Burmeister","year":"2008","journal-title":"FASEB J."},{"issue":"21","key":"10.1016\/j.mcn.2024.103981_bb0230","doi-asserted-by":"crossref","first-page":"18777","DOI":"10.1074\/jbc.M201137200","article-title":"GSTB1-1 from Proteus mirabilis: a snapshot of an enzyme in the evolutionary pathway from a redox enzyme to a conjugating enzyme","volume":"277","author":"Caccuri","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.mcn.2024.103981_bb0235","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1590\/1980-57642020dn14-030006","article-title":"Pharmacological interventions in corticobasal degeneration: a review","volume":"14","author":"Caixeta","year":"2020","journal-title":"Dement. Neuropsychol."},{"issue":"4","key":"10.1016\/j.mcn.2024.103981_bb0240","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2990.1990.tb01264.x","article-title":"Glutathione S-transferase in human brain","volume":"16","author":"Carder","year":"1990","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.mcn.2024.103981_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2024.106528","article-title":"To what extent may aminochrome increase the vulnerability of dopaminergic neurons in the context of Parkinson\u2019s disease","volume":"168","author":"Chagraoui","year":"2024","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"6","key":"10.1016\/j.mcn.2024.103981_bb0250","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1016\/j.clnu.2021.05.011","article-title":"Effect of dietary vitamins C and E on the risk of Parkinson\u2019s disease: a meta-analysis","volume":"40","author":"Chang","year":"2021","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.mcn.2024.103981_bb0255","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.parkreldis.2020.10.024","article-title":"Do caffeine and more selective adenosine a(2A) receptor antagonists protect against dopaminergic neurodegeneration in Parkinson\u2019s disease?","volume":"80 Suppl 1(Suppl 1)","author":"Chen","year":"2020","journal-title":"Parkinsonism Relat. Disord."},{"issue":"8","key":"10.1016\/j.mcn.2024.103981_bb0260","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/hed.21297","article-title":"Glutathione S-transferase P1 and alpha gene variants; role in susceptibility and tumor size development of oral cancer","volume":"32","author":"Chen","year":"2010","journal-title":"Head Neck"},{"issue":"8","key":"10.1016\/j.mcn.2024.103981_bb0265","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1073\/pnas.0813361106","article-title":"Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson\u2019s disease: critical role for the astrocyte","volume":"106","author":"Chen","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.mcn.2024.103981_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/toxics9060142","article-title":"Mechanisms of metal-induced mitochondrial dysfunction in neurological disorders","volume":"9","author":"Cheng","year":"2021","journal-title":"Toxics"},{"issue":"13","key":"10.1016\/j.mcn.2024.103981_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22137080","article-title":"Glutathione S-transferase M3 is associated with glycolysis in intrinsic Temozolomide-resistant glioblastoma Multiforme cells","volume":"22","author":"Cheng","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.mcn.2024.103981_bb0280","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072464","article-title":"Historical perspective: models of Parkinson\u2019s disease","volume":"21","author":"Chia","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb0285","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s13760-022-02144-3","article-title":"X-linked dystonia parkinsonism: epidemiology, genetics, clinical features, diagnosis, and treatment","volume":"123","author":"Chin","year":"2023","journal-title":"Acta Neurol. Belg."},{"issue":"23","key":"10.1016\/j.mcn.2024.103981_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242317027","article-title":"Involvement of mitochondria in Parkinson\u2019s disease","volume":"24","author":"Choong","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb0295","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00018-024-05262-8","article-title":"PRKN-linked familial Parkinson\u2019s disease: cellular and molecular mechanisms of disease-linked variants","volume":"81","author":"Clausen","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.mcn.2024.103981_bb0300","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0076-6879(05)01002-5","article-title":"Human alpha class glutathione S-transferases: genetic polymorphism, expression, and susceptibility to disease","volume":"401","author":"Coles","year":"2005","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.mcn.2024.103981_bb0305","first-page":"1","article-title":"Drug-induced parkinsonism: diagnosis and treatment","author":"Conn","year":"2024","journal-title":"Expert Opin. Drug Saf."},{"issue":"7","key":"10.1016\/j.mcn.2024.103981_bb0310","doi-asserted-by":"crossref","first-page":"5698","DOI":"10.1007\/s12035-017-0791-0","article-title":"Fifty-hertz magnetic field affects the epigenetic modulation of the miR-34b\/c in neuronal cells","volume":"55","author":"Consales","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.mcn.2024.103981_bb0315","first-page":"867","article-title":"GSTP1 and cancer: expression, methylation, polymorphisms and signaling (review)","volume":"56","author":"Cui","year":"2020","journal-title":"Int. J. Oncol."},{"issue":"46","key":"10.1016\/j.mcn.2024.103981_bb0320","doi-asserted-by":"crossref","first-page":"32243","DOI":"10.1074\/jbc.M114.601609","article-title":"The isomerization of Delta5-androstene-3,17-dione by the human glutathione transferase A3-3 proceeds via a conjugated heteroannular diene intermediate","volume":"289","author":"Daka","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.mcn.2024.103981_bb0325","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.tibs.2008.11.002","article-title":"Protein S-glutathionylation: a regulatory device from bacteria to humans","volume":"34","author":"Dalle-Donne","year":"2009","journal-title":"Trends Biochem. Sci."},{"issue":"3","key":"10.1016\/j.mcn.2024.103981_bb0330","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12031074","article-title":"Toxin induced parkinsonism and hospitalization related adverse outcome mitigation for Parkinson\u2019s disease: a comprehensive review","volume":"12","author":"Dalton","year":"2023","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.mcn.2024.103981_bb0335","doi-asserted-by":"crossref","DOI":"10.3390\/genes12071006","article-title":"The genetics of Parkinson\u2019s disease and implications for clinical practice","volume":"12","author":"Day","year":"2021","journal-title":"Genes (Basel)"},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb0340","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.529","article-title":"The fine-tuning of TRAF2-GSTP1-1 interaction: effect of ligand binding and in situ detection of the complex","volume":"5","author":"De Luca","year":"2014","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.mcn.2024.103981_bb0345","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci13030489","article-title":"Treatment of vascular parkinsonism: a systematic review","volume":"13","author":"Del Toro-Perez","year":"2023","journal-title":"Brain Sci."},{"issue":"3","key":"10.1016\/j.mcn.2024.103981_bb0350","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.neulet.2004.05.061","article-title":"Case-only study of interactions between genetic polymorphisms of GSTM1, P1, T1 and Z1 and smoking in Parkinson\u2019s disease","volume":"366","author":"Deng","year":"2004","journal-title":"Neurosci. Lett."},{"issue":"8","key":"10.1016\/j.mcn.2024.103981_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.disamonth.2024.101753","article-title":"Progressive supranuclear palsy: neuropathology, clinical presentation, diagnostic challenges, management, and emerging therapies","volume":"70","author":"DeRosier","year":"2024","journal-title":"Dis. Mon."},{"issue":"22","key":"10.1016\/j.mcn.2024.103981_bb0360","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1056\/NEJMoa2209254","article-title":"Trial of Deferiprone in Parkinson\u2019s disease","volume":"387","author":"Devos","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.mcn.2024.103981_bb0365","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/oem.2006.032078","article-title":"Gene-environment interactions in parkinsonism and Parkinson\u2019s disease: the Geoparkinson study","volume":"64","author":"Dick","year":"2007","journal-title":"Occup. Environ. Med."},{"issue":"47","key":"10.1016\/j.mcn.2024.103981_bb0370","doi-asserted-by":"crossref","first-page":"30843","DOI":"10.1074\/jbc.273.47.30843","article-title":"Roles of CCAAT\/enhancer-binding proteins in regulation of liver regenerative growth","volume":"273","author":"Diehl","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcn.2024.103981_bb0375","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.nbd.2016.05.011","article-title":"Ferroptosis, a newly characterized form of cell death in Parkinson\u2019s disease that is regulated by PKC","volume":"94","author":"Do Van","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.mcn.2024.103981_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101107","article-title":"NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis","volume":"23","author":"Dodson","year":"2019","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.mcn.2024.103981_bb0385","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10863-019-09798-4","article-title":"Role of DJ-1 in the mechanism of pathogenesis of Parkinson\u2019s disease","volume":"51","author":"Dolgacheva","year":"2019","journal-title":"J. Bioenerg. Biomembr."},{"issue":"34","key":"10.1016\/j.mcn.2024.103981_bb0390","doi-asserted-by":"crossref","first-page":"30792","DOI":"10.1074\/jbc.M203642200","article-title":"Activation of the p38 signaling pathway by heat shock involves the dissociation of glutathione S-transferase mu from Ask1","volume":"277","author":"Dorion","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.mcn.2024.103981_bb0395","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3233\/JPD-225047","article-title":"Trichloroethylene: an invisible cause of Parkinson\u2019s disease?","volume":"13","author":"Dorsey","year":"2023","journal-title":"J. Parkinsons Dis."},{"issue":"31","key":"10.1016\/j.mcn.2024.103981_bb0400","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1021\/jp410810q","article-title":"Isomerization of Delta5-androstene-3,17-dione into Delta4-androstene-3,17-dione catalyzed by human glutathione transferase A3-3: a computational study identifies a dual role for glutathione","volume":"118","author":"Dourado","year":"2014","journal-title":"J. Phys. Chem. A"},{"issue":"3","key":"10.1016\/j.mcn.2024.103981_bb0405","article-title":"Antioxidant therapeutics in Parkinson\u2019s disease: current challenges and opportunities","volume":"10","author":"Duarte-Jurado","year":"2021","journal-title":"Antioxidants (Basel)"},{"issue":"5","key":"10.1016\/j.mcn.2024.103981_bb0410","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1074\/jbc.M007874200","article-title":"The glutathione transferase structural family includes a nuclear chloride channel and a ryanodine receptor calcium release channel modulator","volume":"276","author":"Dulhunty","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.mcn.2024.103981_bb0415","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3109\/03602532.2010.549134","article-title":"Regulation of the cardiac muscle ryanodine receptor by glutathione transferases","volume":"43","author":"Dulhunty","year":"2011","journal-title":"Drug Metab. Rev."},{"issue":"4","key":"10.1016\/j.mcn.2024.103981_bb0420","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s40120-024-00614-9","article-title":"Pharmacotherapies for the treatment of progressive Supranuclear palsy: a narrative review","volume":"13","author":"Dunning","year":"2024","journal-title":"Neurol. Ther."},{"issue":"6","key":"10.1016\/j.mcn.2024.103981_bb0425","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00109-013-1038-9","article-title":"Alpha-synuclein and intracellular trafficking: impact on the spreading of Parkinson\u2019s disease pathology","volume":"91","author":"Eisbach","year":"2013","journal-title":"J. Mol. Med. (Berl)"},{"issue":"4","key":"10.1016\/j.mcn.2024.103981_bb0430","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41582-019-0155-7","article-title":"Emerging therapies in Parkinson disease - repurposed drugs and new approaches","volume":"15","author":"Elkouzi","year":"2019","journal-title":"Nat. Rev. Neurol."},{"issue":"10","key":"10.1016\/j.mcn.2024.103981_bb0435","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1002\/acn3.50889","article-title":"Rescue levodopa-carbidopa intestinal gel (LCIG) therapy in Parkinson\u2019s disease patients with suboptimal response to deep brain stimulation","volume":"6","author":"Elkouzi","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"2","key":"10.1016\/j.mcn.2024.103981_bb0440","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/aje\/kwf018","article-title":"Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review","volume":"156","author":"Engel","year":"2002","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.mcn.2024.103981_bb0445","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.freeradbiomed.2022.07.013","article-title":"Nrf2 as a regulator of mitochondrial function: energy metabolism and beyond","volume":"189","author":"Esteras","year":"2022","journal-title":"Free Radic. Biol. Med."},{"issue":"16","key":"10.1016\/j.mcn.2024.103981_bb0450","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21165624","article-title":"Involvement of p38 MAPK in synaptic function and dysfunction","volume":"21","author":"Falcicchia","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mcn.2024.103981_bb0455","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.888942","article-title":"Polymorphisms of cytochromes P450 and glutathione S-transferases synergistically modulate risk for Parkinson\u2019s disease","volume":"14","author":"Fan","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"5","key":"10.1016\/j.mcn.2024.103981_bb0460","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000014228","article-title":"Compound heterozygous mutations in PARK2 causing early-onset Parkinson disease: a case report","volume":"98","author":"Fang","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.mcn.2024.103981_bb0465","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.2147\/TCRM.S360268","article-title":"Updated perspectives on the Management of Drug-Induced Parkinsonism (DIP): insights from the clinic","volume":"18","author":"Feldman","year":"2022","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.mcn.2024.103981_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117345","article-title":"The benefits and mechanisms of exercise training for Parkinson\u2019s disease","volume":"245","author":"Feng","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.mcn.2024.103981_bb0475","article-title":"Post-traumatic parkinsonism: the intricate twist between trauma, inflammation and neurodegeneration","volume":"466","author":"Ferrazzoli","year":"2024","journal-title":"A narrative review. J. Neurol. Sci."},{"issue":"8","key":"10.1016\/j.mcn.2024.103981_bb0480","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/humu.22808","article-title":"Structural and functional impact of Parkinson disease-associated mutations in the E3 ubiquitin ligase Parkin","volume":"36","author":"Fiesel","year":"2015","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.mcn.2024.103981_bb0485","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.chemosphere.2017.05.039","article-title":"Hydroxyl radical yields in the Fenton process under various pH, ligand concentrations and hydrogen peroxide\/Fe(II) ratios","volume":"182","author":"Fischbacher","year":"2017","journal-title":"Chemosphere"},{"issue":"2","key":"10.1016\/j.mcn.2024.103981_bb0490","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3109\/03602532.2011.560157","article-title":"Sigma-class glutathione transferases","volume":"43","author":"Flanagan","year":"2011","journal-title":"Drug Metab. Rev."},{"issue":"9","key":"10.1016\/j.mcn.2024.103981_bb0495","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094643","article-title":"Genes implicated in familial Parkinson\u2019s disease provide a dual picture of Nigral dopaminergic neurodegeneration with mitochondria taking center stage","volume":"22","author":"Franco","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.mcn.2024.103981_bb0500","first-page":"169","article-title":"Nrf2 activation attenuates the early suppression of mitochondrial respiration due to the alpha-synuclein overexpression","volume":"41","author":"Fu","year":"2018","journal-title":"Biom. J."},{"issue":"6","key":"10.1016\/j.mcn.2024.103981_bb0505","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000052636","article-title":"Increased expression of glutathione S-transferase in renal proximal tubules in the early stages of diabetes: a study of type-2 diabetes in the Akita mouse model","volume":"9","author":"Fujita","year":"2001","journal-title":"Exp. Nephrol."},{"issue":"49","key":"10.1016\/j.mcn.2024.103981_bb0510","doi-asserted-by":"crossref","first-page":"17775","DOI":"10.1523\/JNEUROSCI.3049-12.2012","article-title":"Astrocyte-specific overexpression of Nrf2 delays motor pathology and synuclein aggregation throughout the CNS in the alpha-synuclein mutant (A53T) mouse model","volume":"32","author":"Gan","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcn.2024.103981_bb0515","article-title":"Dissecting the crosstalk between Nrf2 and NF-kappaB response pathways in drug-induced toxicity","volume":"9","author":"Gao","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.mcn.2024.103981_bb0520","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12050770","article-title":"Dysregulated miRNAs as biomarkers and Therapeutical targets in neurodegenerative diseases","volume":"12","author":"Gentile","year":"2022","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.mcn.2024.103981_bb0525","first-page":"69","article-title":"Molecular and cellular aspects of thiol-disulfide exchange","volume":"63","author":"Gilbert","year":"1990","journal-title":"Adv. Enzymol. Relat. Areas Mol. Biol."},{"issue":"13","key":"10.1016\/j.mcn.2024.103981_bb0530","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/mds.25216","article-title":"Genetic modification of the association of paraquat and Parkinson\u2019s disease","volume":"27","author":"Goldman","year":"2012","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/reveh-2020-0140","article-title":"Environmental and occupational exposure to metals (manganese, mercury, iron) and Parkinson\u2019s disease in low and middle-income countries: a narrative review","volume":"37","author":"Gonzalez-Alvarez","year":"2022","journal-title":"Rev. Environ. Health"},{"issue":"15","key":"10.1016\/j.mcn.2024.103981_bb0540","doi-asserted-by":"crossref","DOI":"10.3390\/nu15153454","article-title":"Polyphenols and their impact on the prevention of neurodegenerative diseases and development","volume":"15","author":"Grabska-Kobylecka","year":"2023","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.mcn.2024.103981_bb0545","doi-asserted-by":"crossref","first-page":"e698","DOI":"10.1212\/WNL.0000000000200699","article-title":"Genome-wide association and Meta-analysis of age at onset in Parkinson disease: evidence from the COURAGE-PD consortium","volume":"99","author":"Grover","year":"2022","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.mcn.2024.103981_bb0550","doi-asserted-by":"crossref","DOI":"10.3390\/cells10081850","article-title":"Activation of Nrf2 in astrocytes suppressed PD-like phenotypes via antioxidant and autophagy pathways in rat and Drosophila models","volume":"10","author":"Guo","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb0555","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1124\/dmd.105.003996","article-title":"Inhibition and recovery of rat hepatic glutathione S-transferase zeta and alteration of tyrosine metabolism following dichloroacetate exposure and withdrawal","volume":"34","author":"Guo","year":"2006","journal-title":"Drug Metab. Dispos."},{"issue":"7324","key":"10.1016\/j.mcn.2024.103981_bb0560","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nature09536","article-title":"Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1","volume":"468","author":"Guzman","year":"2010","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.mcn.2024.103981_bb0565","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tibs.2014.02.002","article-title":"The Nrf2 regulatory network provides an interface between redox and intermediary metabolism","volume":"39","author":"Hayes","year":"2014","journal-title":"Trends Biochem. Sci."},{"issue":"6","key":"10.1016\/j.mcn.2024.103981_bb0570","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3109\/10409239509083491","article-title":"The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance","volume":"30","author":"Hayes","year":"1995","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.mcn.2024.103981_bb0575","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000028396","article-title":"Glutathione S-transferase polymorphisms and their biological consequences","volume":"61","author":"Hayes","year":"2000","journal-title":"Pharmacology"},{"issue":"13","key":"10.1016\/j.mcn.2024.103981_bb0580","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21134777","article-title":"NRF2, a transcription factor for stress response and beyond","volume":"21","author":"He","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.mcn.2024.103981_bb0585","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22403","article-title":"CYP2E1 and GSTM1 gene polymorphisms, environmental factors, and the susceptibility to lung cancer","volume":"32","author":"He","year":"2018","journal-title":"J. Clin. Lab. Anal."},{"issue":"18","key":"10.1016\/j.mcn.2024.103981_bb0590","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1007\/s00018-016-2182-5","article-title":"Aminochrome induces dopaminergic neuronal dysfunction: a new animal model for Parkinson\u2019s disease","volume":"73","author":"Herrera","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.mcn.2024.103981_bb0595","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1021\/acschemneuro.7b00034","article-title":"Are dopamine oxidation metabolites involved in the loss of dopaminergic neurons in the nigrostriatal system in Parkinson\u2019s disease?","volume":"8","author":"Herrera","year":"2017","journal-title":"ACS Chem. Neurosci."},{"issue":"4","key":"10.1016\/j.mcn.2024.103981_bb0600","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3390\/ijerph13040379","article-title":"The association between gene-environment interactions and diseases involving the human GST superfamily with SNP variants","volume":"13","author":"Hollman","year":"2016","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"11","key":"10.1016\/j.mcn.2024.103981_bb0605","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.freeradbiomed.2010.09.005","article-title":"The use of thiols by ribonucleotide reductase","volume":"49","author":"Holmgren","year":"2010","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb0610","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12035-022-03086-w","article-title":"Dysregulation of circulatory levels of lncRNAs in Parkinson\u2019s disease","volume":"60","author":"Huang","year":"2023","journal-title":"Mol. Neurobiol."},{"issue":"11","key":"10.1016\/j.mcn.2024.103981_bb0615","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11113094","article-title":"On the role of Iron in idiopathic Parkinson\u2019s disease","volume":"11","author":"Huenchuguala","year":"2023","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.mcn.2024.103981_bb0620","article-title":"Natural compounds that activate the KEAP1\/Nrf2 signaling pathway as potential new drugs in the treatment of idiopathic Parkinson\u2019s disease","volume":"13","author":"Huenchuguala","year":"2024","journal-title":"Antioxidants (Basel)"},{"issue":"6","key":"10.1016\/j.mcn.2024.103981_bb0625","doi-asserted-by":"crossref","DOI":"10.3390\/biom14060673","article-title":"Targets to search for new pharmacological treatment in idiopathic Parkinson\u2019s disease according to the single-neuron degeneration model","volume":"14","author":"Huenchuguala","year":"2024","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.mcn.2024.103981_bb0630","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4103\/1673-5374.380878","article-title":"Single-neuron neurodegeneration as a degenerative model for Parkinson\u2019s disease","volume":"19","author":"Huenchuguala","year":"2024","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.mcn.2024.103981_bb0635","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ibneur.2024.04.008","article-title":"Progressive Supranuclear palsy syndrome: an overview","volume":"16","author":"Ichikawa-Escamilla","year":"2024","journal-title":"IBRO Neurosci. Rep."},{"issue":"2","key":"10.1016\/j.mcn.2024.103981_bb0640","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.nbd.2011.04.007","article-title":"The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson\u2019s disease","volume":"43","author":"Ilijic","year":"2011","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.mcn.2024.103981_bb0645","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1212\/01.wnl.0000201252.57661.e1","article-title":"A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease","volume":"66","author":"Investigators","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.mcn.2024.103981_bb0650","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.pharmthera.2016.10.018","article-title":"Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1","volume":"170","author":"James","year":"2017","journal-title":"Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.mcn.2024.103981_bb0655","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","article-title":"Parkinson\u2019s disease: etiopathogenesis and treatment","volume":"91","author":"Jankovic","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.mcn.2024.103981_bb0660","first-page":"27(16)","article-title":"Activation of Nrf2 by Esculetin mitigates inflammatory responses through suppression of NF-kappaB signaling Cascade in RAW 264.7 cells","author":"Jayakumar","year":"2022","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.mcn.2024.103981_bb0665","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s00702-023-02691-w","article-title":"Pathomechanisms of cognitive and behavioral impairment in corticobasal degeneration","volume":"130","author":"Jellinger","year":"2023","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"19","key":"10.1016\/j.mcn.2024.103981_bb0670","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/15287394.2016.1193113","article-title":"Effects of testosterone on synaptic plasticity mediated by androgen receptors in male SAMP8 mice","volume":"79","author":"Jia","year":"2016","journal-title":"J. Toxicol. Environ. Health A"},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb0675","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s42003-022-03251-w","article-title":"Glutathione S-transferase mu 2 inhibits hepatic steatosis via ASK1 suppression","volume":"5","author":"Jin","year":"2022","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb0680","article-title":"The genetic landscape of sleep disorders in Parkinson\u2019s disease","volume":"14","author":"Kalinderi","year":"2024","journal-title":"Diagnostics (Basel)"},{"issue":"569","key":"10.1016\/j.mcn.2024.103981_bb0685","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aar2124","article-title":"Glutathione S-transferases promote proinflammatory astrocyte-microglia communication during brain inflammation","volume":"12","author":"Kano","year":"2019","journal-title":"Sci. Signal."},{"issue":"5","key":"10.1016\/j.mcn.2024.103981_bb0690","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/em.22362","article-title":"Interaction of glutathione-s-transferase genotypes with environmental risk factors in determining susceptibility to head and neck cancer and treatment response and survival outcome","volume":"61","author":"Katiyar","year":"2020","journal-title":"Environ. Mol. Mutagen."},{"issue":"4","key":"10.1016\/j.mcn.2024.103981_bb0695","article-title":"Epigenome-wide analysis of DNA methylation in Parkinson\u2019s disease cortex","volume":"12","author":"Kaut","year":"2022","journal-title":"Life (Basel)"},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb0700","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(02)01286-7","article-title":"Glutathione S-transferase M1, T1, and P1 polymorphisms and Parkinson\u2019s disease","volume":"337","author":"Kelada","year":"2003","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.mcn.2024.103981_bb0705","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/MS9.0000000000001664","article-title":"Insights into the management of Lewy body dementia: a scoping review","volume":"86","author":"Khan","year":"2024","journal-title":"Ann. Med. Surg. (Lond.)"},{"issue":"2","key":"10.1016\/j.mcn.2024.103981_bb0710","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1042\/BST20180462","article-title":"LRRK2 links genetic and sporadic Parkinson\u2019s disease","volume":"47","author":"Kluss","year":"2019","journal-title":"Biochem. Soc. Trans."},{"issue":"21","key":"10.1016\/j.mcn.2024.103981_bb0715","doi-asserted-by":"crossref","DOI":"10.3390\/nu14214472","article-title":"The role of diet and dietary patterns in Parkinson\u2019s disease","volume":"14","author":"Knight","year":"2022","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.mcn.2024.103981_bb0720","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.3233\/JPD-223380","article-title":"Early-onset Parkinson\u2019s disease: creating the right environment for a genetic disorder","volume":"12","author":"Kolicheski","year":"2022","journal-title":"J. Parkinsons Dis."},{"issue":"3","key":"10.1016\/j.mcn.2024.103981_bb0725","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3892\/ol.2012.1098","article-title":"GSTP1 negatively regulates Stat3 activation in epidermal growth factor signaling","volume":"5","author":"Kou","year":"2013","journal-title":"Oncol. Lett."},{"issue":"4\u20135","key":"10.1016\/j.mcn.2024.103981_bb0730","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.brainresbull.2009.06.018","article-title":"Neuropathology of Lewy body disorders","volume":"80","author":"Kovari","year":"2009","journal-title":"Brain Res. Bull."},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb0735","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000494496","article-title":"Glutathione S-transferases and cytochrome P450 enzyme expression in patients with intracranial tumors: preliminary report of 55 patients","volume":"28","author":"Kural","year":"2019","journal-title":"Med. Princ. Pract."},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb0740","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl. Neurodegener."},{"issue":"19","key":"10.1016\/j.mcn.2024.103981_bb0745","doi-asserted-by":"crossref","first-page":"16567","DOI":"10.1074\/jbc.M211596200","article-title":"Glutathione s-transferase omega 1-1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1beta posttranslational processing","volume":"278","author":"Laliberte","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.mcn.2024.103981_bb0750","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1383-5742(00)00050-8","article-title":"Mammalian class theta GST and differential susceptibility to carcinogens: a review","volume":"463","author":"Landi","year":"2000","journal-title":"Mutat. Res."},{"issue":"11","key":"10.1016\/j.mcn.2024.103981_bb0755","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a003996","article-title":"Ryanodine receptors: structure, expression, molecular details, and function in calcium release","volume":"2","author":"Lanner","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"6","key":"10.1016\/j.mcn.2024.103981_bb0760","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1124\/dmd.30.6.616","article-title":"Immunohistochemical localization and activity of glutathione transferase zeta (GSTZ1-1) in rat tissues","volume":"30","author":"Lantum","year":"2002","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb0765","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ab.2011.01.024","article-title":"Quantitative and selective polymerase chain reaction analysis of highly similar human alpha-class glutathione transferases","volume":"412","author":"Larsson","year":"2011","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.mcn.2024.103981_bb0770","doi-asserted-by":"crossref","first-page":"1378175","DOI":"10.1155\/2017\/1378175","article-title":"Collaborative power of Nrf2 and PPARgamma activators against metabolic and drug-induced oxidative injury","volume":"2017","author":"Lee","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"6","key":"10.1016\/j.mcn.2024.103981_bb0775","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1177\/1535370215579162","article-title":"LRRK2 mutations and neurotoxicant susceptibility","volume":"240","author":"Lee","year":"2015","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"40","key":"10.1016\/j.mcn.2024.103981_bb0780","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1038\/s41388-022-02444-1","article-title":"GSTM2 is a key molecular determinant of resistance to SG-ARIs","volume":"41","author":"Li","year":"2022","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb0785","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1186\/s13046-019-1459-6","article-title":"GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1\/NRF2 pathway","volume":"38","author":"Li","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.mcn.2024.103981_bb0790","doi-asserted-by":"crossref","first-page":"683","DOI":"10.7150\/ijms.5947","article-title":"Glutathione S-transferase P1 correlated with oxidative stress in hepatocellular carcinoma","volume":"10","author":"Li","year":"2013","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.mcn.2024.103981_bb0795","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuroscience.2013.03.045","article-title":"The regulatory role of NF-kappaB in autophagy-like cell death after focal cerebral ischemia in mice","volume":"244","author":"Li","year":"2013","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.mcn.2024.103981_bb0800","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1096\/fj.11-200279","article-title":"Eicosanoid receptor subtype-mediated opposing regulation of TLR-stimulated expression of astrocyte glial-derived neurotrophic factor","volume":"26","author":"Li","year":"2012","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.mcn.2024.103981_bb0805","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/mds.20120","article-title":"Recent failures of new potential symptomatic treatments for Parkinson\u2019s disease: causes and solutions","volume":"19","author":"Linazasoro","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.mcn.2024.103981_bb0810","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jsbmb.2017.11.011","article-title":"Characterization of equine GST A3-3 as a steroid isomerase","volume":"178","author":"Lindstrom","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"11","key":"10.1016\/j.mcn.2024.103981_bb0815","first-page":"20918","article-title":"Predictive potential role of GSTs gene polymorphisms in the treatment outcome of advanced non-small cell lung cancer patients","volume":"8","author":"Liu","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.mcn.2024.103981_bb0820","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.959291","article-title":"Individual and combined effects of the GSTM1, GSTT1, and GSTP1 polymorphisms on type 2 diabetes mellitus risk: a systematic review and meta-analysis","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.mcn.2024.103981_bb0825","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.627140","article-title":"Deactivation of the JNK pathway by GSTP1 is essential to maintain sperm functionality","volume":"9","author":"Llavanera","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.mcn.2024.103981_bb0830","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.3933","article-title":"The neuroprotective effect of nicotine in Parkinson's disease models is associated with inhibiting PARP-1 and caspase-3 cleavage","volume":"5","author":"Lu","year":"2017","journal-title":"PeerJ"},{"key":"10.1016\/j.mcn.2024.103981_bb0835","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2020.101890","article-title":"Ferroptosis and its potential role in the physiopathology of Parkinson\u2019s disease","volume":"196","author":"Mahoney-Sanchez","year":"2021","journal-title":"Prog. Neurobiol."},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb0840","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s13148-021-01208-0","article-title":"Genome-wide methylation and expression analyses reveal the epigenetic landscape of immune-related diseases for tobacco smoking","volume":"13","author":"Mao","year":"2021","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.mcn.2024.103981_bb0845","doi-asserted-by":"crossref","first-page":"1080140","DOI":"10.3389\/fmolb.2022.1080140","article-title":"Glutathione S-transferases control astrocyte activation and neuronal health during neuroinflammation","volume":"9","author":"Matoba","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"3","key":"10.1016\/j.mcn.2024.103981_bb0850","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1474-9726.2007.00275.x","article-title":"Calcium and neurodegeneration","volume":"6","author":"Mattson","year":"2007","journal-title":"Aging Cell"},{"issue":"4","key":"10.1016\/j.mcn.2024.103981_bb0855","doi-asserted-by":"crossref","DOI":"10.3390\/biom13040688","article-title":"The multifaceted role of glutathione S-transferases in health and disease","volume":"13","author":"Mazari","year":"2023","journal-title":"Biomolecules"},{"issue":"20","key":"10.1016\/j.mcn.2024.103981_bb0860","doi-asserted-by":"crossref","first-page":"7853","DOI":"10.1074\/jbc.RA118.001949","article-title":"Inflammation-induced iron transport and metabolism by brain microglia","volume":"293","author":"McCarthy","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.mcn.2024.103981_bb0865","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ncl.2020.08.003","article-title":"Toxin-induced parkinsonism","volume":"38","author":"McKnight","year":"2020","journal-title":"Neurol. Clin."},{"issue":"44","key":"10.1016\/j.mcn.2024.103981_bb0870","doi-asserted-by":"crossref","first-page":"18838","DOI":"10.1073\/pnas.1007387107","article-title":"Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals","volume":"107","author":"McMahon","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.mcn.2024.103981_bb0875","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1242\/jcs.167858","article-title":"GSTO1-1 modulates metabolism in macrophages activated through the LPS and TLR4 pathway","volume":"128","author":"Menon","year":"2015","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb0880","doi-asserted-by":"crossref","first-page":"17832","DOI":"10.1038\/s41598-017-17861-6","article-title":"GSTO1-1 plays a pro-inflammatory role in models of inflammation, colitis and obesity","volume":"7","author":"Menon","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mcn.2024.103981_bb0885","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.neuro.2019.07.007","article-title":"The role of zinc, copper, manganese and iron in neurodegenerative diseases","volume":"74","author":"Mezzaroba","year":"2019","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.mcn.2024.103981_bb0890","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2020.111332","article-title":"Role of non-coding RNAs in age-related vascular cognitive impairment: an overview on diagnostic\/prognostic value in vascular dementia and vascular parkinsonism","volume":"191","author":"Miceli","year":"2020","journal-title":"Mech. Ageing Dev."},{"issue":"10","key":"10.1016\/j.mcn.2024.103981_bb0895","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1001\/jamaneurol.2021.1312","article-title":"Emerging neuroimaging biomarkers across disease stage in Parkinson disease: a review","volume":"78","author":"Mitchell","year":"2021","journal-title":"JAMA Neurol."},{"issue":"7","key":"10.1016\/j.mcn.2024.103981_bb0900","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.bcp.2003.10.036","article-title":"Regulation of glutathione S-transferase P1-1 gene expression by NF-kappaB in tumor necrosis factor alpha-treated K562 leukemia cells","volume":"67","author":"Morceau","year":"2004","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.mcn.2024.103981_bb0905","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3109\/03602532.2011.558511","article-title":"Microsomal glutathione transferase 1: mechanism and functional roles","volume":"43","author":"Morgenstern","year":"2011","journal-title":"Drug Metab. Rev."},{"issue":"6","key":"10.1016\/j.mcn.2024.103981_bb0910","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0043-1777775","article-title":"The clinical diagnosis of Parkinson\u2019s disease","volume":"82","author":"Munhoz","year":"2024","journal-title":"Arq. Neuropsiquiatr."},{"issue":"3","key":"10.1016\/j.mcn.2024.103981_bb0915","first-page":"345","article-title":"Glutathione S-transferase P1 (GSTP1) suppresses cell apoptosis and its regulation by miR-133alpha in head and neck squamous cell carcinoma (HNSCC)","volume":"27","author":"Mutallip","year":"2011","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.mcn.2024.103981_bb0920","article-title":"Multiple system atrophy: diagnostic challenges and a proposed diagnostic algorithm","volume":"11","author":"Nandanwar","year":"2024","journal-title":"Clin. Park. Relat. Disord."},{"issue":"9","key":"10.1016\/j.mcn.2024.103981_bb0925","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph13090881","article-title":"Environmental exposures and Parkinson\u2019s disease","volume":"13","author":"Nandipati","year":"2016","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"Pt 1","key":"10.1016\/j.mcn.2024.103981_bb0930","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1042\/bj20021765","article-title":"The role of an evolutionarily conserved cis-proline in the thioredoxin-like domain of human class alpha glutathione transferase A1-1","volume":"372","author":"Nathaniel","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.mcn.2024.103981_bb0935","article-title":"Multiple system atrophy: pathology, pathogenesis, and path forward","volume":"20","author":"Ndayisaba","year":"2024","journal-title":"Annu. Rev. Pathol."},{"issue":"6","key":"10.1016\/j.mcn.2024.103981_bb0940","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/1479-7364-1-6-460","article-title":"Analysis of the glutathione S-transferase (GST) gene family","volume":"1","author":"Nebert","year":"2004","journal-title":"Hum. Genomics"},{"issue":"36","key":"10.1016\/j.mcn.2024.103981_bb0945","doi-asserted-by":"crossref","first-page":"11257","DOI":"10.1523\/JNEUROSCI.2375-09.2009","article-title":"Parkin protects against LRRK2 G2019S mutant-induced dopaminergic neurodegeneration in Drosophila","volume":"29","author":"Ng","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcn.2024.103981_bb0950","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.826193","article-title":"Evidence that substantia Nigra pars compacta dopaminergic neurons are selectively vulnerable to oxidative stress because they are highly metabolically active","volume":"16","author":"Ni","year":"2022","journal-title":"Front. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.mcn.2024.103981_bb0955","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/jnc.15561","article-title":"Dopaminergic imaging in degenerative parkinsonisms, an established clinical diagnostic tool","volume":"164","author":"Nicastro","year":"2023","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mcn.2024.103981_bb0960","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.parkreldis.2019.06.025","article-title":"Juvenile parkinsonism: differential diagnosis, genetics, and treatment","volume":"67","author":"Niemann","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"issue":"2","key":"10.1016\/j.mcn.2024.103981_bb0965","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3109\/03602532.2011.558093","article-title":"Glutathione transferases: a structural perspective","volume":"43","author":"Oakley","year":"2011","journal-title":"Drug Metab. Rev."},{"issue":"52","key":"10.1016\/j.mcn.2024.103981_bb0970","doi-asserted-by":"crossref","first-page":"30866","DOI":"10.1074\/jbc.M115.656140","article-title":"Phosphorylation of glutathione S-transferase P1 (GSTP1) by epidermal growth factor receptor (EGFR) promotes formation of the GSTP1-c-Jun N-terminal kinase (JNK) complex and suppresses JNK downstream signaling and apoptosis in brain tumor cells","volume":"290","author":"Okamura","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.mcn.2024.103981_bb0975","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/jb\/mvac013","article-title":"CEBPB is required for NRF2-mediated drug resistance in NRF2-activated non-small cell lung cancer cells","volume":"171","author":"Okazaki","year":"2022","journal-title":"J. Biochem."},{"issue":"5","key":"10.1016\/j.mcn.2024.103981_bb0980","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archneur.59.5.807","article-title":"Refractory nonmotor symptoms in male patients with Parkinson disease due to testosterone deficiency: a common unrecognized comorbidity","volume":"59","author":"Okun","year":"2002","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb0985","first-page":"165","article-title":"Testosterone deficiency in a Parkinson\u2019s disease clinic: results of a survey","volume":"75","author":"Okun","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"9","key":"10.1016\/j.mcn.2024.103981_bb0990","doi-asserted-by":"crossref","DOI":"10.3390\/nu12092763","article-title":"Milk and fermented Milk intake and Parkinson\u2019s disease: cohort study","volume":"12","author":"Olsson","year":"2020","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.mcn.2024.103981_bb0995","article-title":"Oxidative stress and antioxidants in neurodegenerative disorders","volume":"12","author":"Olufunmilayo","year":"2023","journal-title":"Antioxidants (Basel)"},{"issue":"16","key":"10.1016\/j.mcn.2024.103981_bb1000","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1212\/01.wnl.0000277637.33328.d8","article-title":"The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?","volume":"69","author":"Orr-Urtreger","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.mcn.2024.103981_bb1005","first-page":"187","article-title":"Behavioral changes in frontotemporal dementia with parkinsonism","volume":"96","author":"Pace-Savitsky","year":"2005","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.mcn.2024.103981_bb1010","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.705407","article-title":"A phase II study to evaluate the safety and efficacy of Prasinezumab in early Parkinson\u2019s disease (PASADENA): rationale, design, and baseline data","volume":"12","author":"Pagano","year":"2021","journal-title":"Front. Neurol."},{"issue":"5","key":"10.1016\/j.mcn.2024.103981_bb1015","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa2202867","article-title":"Trial of Prasinezumab in early-stage Parkinson\u2019s disease","volume":"387","author":"Pagano","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mcn.2024.103981_bb1020","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.redox.2017.01.006","article-title":"Modulation of proteostasis by transcription factor NRF2 and impact in neurodegenerative diseases","volume":"11","author":"Pajares","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.mcn.2024.103981_bb1025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40035-019-0165-9","article-title":"The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson's disease","volume":"8","author":"Pang","year":"2019","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.mcn.2024.103981_bb1030","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103077","article-title":"Regulation of immunomodulatory networks by Nrf2-activation in immune cells: redox control and therapeutic potential in inflammatory diseases","volume":"70","author":"Pant","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.mcn.2024.103981_bb1035","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2020.110872","article-title":"Effects of Gsta4 deficiency on age-related cochlear pathology and hearing loss in mice","volume":"133","author":"Park","year":"2020","journal-title":"Exp. Gerontol."},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb1040","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-022-01078-9","article-title":"The role of histone modifications: from neurodevelopment to neurodiseases","volume":"7","author":"Park","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.mcn.2024.103981_bb1045","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/jamaneurol.2014.131","article-title":"A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit","volume":"71","author":"Parkinson Study Group","year":"2014","journal-title":"JAMA Neurol."},{"issue":"9","key":"10.1016\/j.mcn.2024.103981_bb1050","doi-asserted-by":"crossref","first-page":"591","DOI":"10.7326\/M19-2534","article-title":"Isradipine versus placebo in early Parkinson disease: a randomized trial","volume":"172","author":"Parkinson Study Group","year":"2020","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb1055","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/mds.27577","article-title":"The association between lifestyle factors and Parkinson\u2019s disease progression and mortality","volume":"34","author":"Paul","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.mcn.2024.103981_bb1060","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.freeradbiomed.2015.11.006","article-title":"Glutathione-S-transferase omega 1 (GSTO1-1) acts as mediator of signaling pathways involved in aflatoxin B1-induced apoptosis-autophagy crosstalk in macrophages","volume":"89","author":"Paul","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mcn.2024.103981_bb1065","doi-asserted-by":"crossref","unstructured":"Pemble, S., et al., Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem. J., 1994. 300 ( Pt 1)(Pt 1): p. 271\u20136.","DOI":"10.1042\/bj3000271"},{"issue":"7","key":"10.1016\/j.mcn.2024.103981_bb1070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072316","article-title":"Role of alcohol drinking in Alzheimer\u2019s disease, Parkinson\u2019s disease, and amyotrophic lateral sclerosis","volume":"21","author":"Peng","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mcn.2024.103981_bb1075","doi-asserted-by":"crossref","first-page":"1146377","DOI":"10.3389\/fmolb.2023.1146377","article-title":"Editorial: the expanding functional network of glutathione transferases","volume":"10","author":"Piaggi","year":"2023","journal-title":"Front. Mol. Biosci."},{"issue":"2","key":"10.1016\/j.mcn.2024.103981_bb1080","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","article-title":"The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson\u2019s disease","volume":"85","author":"Pickrell","year":"2015","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.mcn.2024.103981_bb1085","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1590\/0004-282X20130076","article-title":"Nullity of GSTT1\/GSTM1 related to pesticides is associated with Parkinson\u2019s disease","volume":"71","author":"Pinhel","year":"2013","journal-title":"Arq. Neuropsiquiatr."},{"issue":"6","key":"10.1016\/j.mcn.2024.103981_bb1090","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.3390\/clinpract13060128","article-title":"Neuroimaging techniques in differentiating Parkinson\u2019s disease from drug-induced parkinsonism: a comprehensive review","volume":"13","author":"Pitton Rissardo","year":"2023","journal-title":"Clin. Pract."},{"issue":"10","key":"10.1016\/j.mcn.2024.103981_bb1095","first-page":"709","article-title":"Neurological manifestations of excessive alcohol consumption","volume":"40","author":"Planas-Ballve","year":"2017","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.mcn.2024.103981_bb1100","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.freeradbiomed.2014.11.013","article-title":"The basics of thiols and cysteines in redox biology and chemistry","volume":"80","author":"Poole","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.mcn.2024.103981_bb1105","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.2019","article-title":"Association of Parkinson's disease to Parkinson's plus syndromes, Lewy body dementia, and Alzheimer's dementia","volume":"7","author":"Prajjwal","year":"2024","journal-title":"Health Sci. Rep."},{"issue":"6","key":"10.1016\/j.mcn.2024.103981_bb1110","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1128\/MCB.01204-10","article-title":"SCF\/beta-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner","volume":"31","author":"Rada","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.mcn.2024.103981_bb1115","first-page":"19","article-title":"Dopa-responsive dystonia","volume":"138","author":"Randby","year":"2018","journal-title":"Tidsskr. Nor. Laegeforen."},{"issue":"7 Suppl","key":"10.1016\/j.mcn.2024.103981_bb1120","first-page":"S51","article-title":"\u201cdisease-modification\u201d trials in Parkinson disease: target populations, endpoints and study design","volume":"72","author":"Rascol","year":"2009","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.mcn.2024.103981_bb1125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094956","article-title":"Epigenetic regulation of Neuroinflammation in Parkinson\u2019s disease","volume":"22","author":"Rasheed","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"22","key":"10.1016\/j.mcn.2024.103981_bb1130","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1111\/j.1742-4658.2011.08358.x","article-title":"Dual localization of glutathione S-transferase in the cytosol and mitochondria: implications in oxidative stress, toxicity and disease","volume":"278","author":"Raza","year":"2011","journal-title":"FEBS J."},{"issue":"10","key":"10.1016\/j.mcn.2024.103981_bb1135","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2174\/1386207323666200428082815","article-title":"GC-MS based metabolic profiling of Parkinson\u2019s disease with glutathione S-transferase M1 and T1 polymorphism in Tunisian patients","volume":"23","author":"Rebai","year":"2020","journal-title":"Comb. Chem. High Throughput Screen."},{"issue":"3","key":"10.1016\/j.mcn.2024.103981_bb1140","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.neurol.2020.03.013","article-title":"Effects of glutathione S-transferase M1 and T1 deletions on Parkinson\u2019s disease risk among a north African population","volume":"177","author":"Rebai","year":"2021","journal-title":"Rev. Neurol. (Paris)"},{"issue":"4","key":"10.1016\/j.mcn.2024.103981_bb1145","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s40572-022-00371-7","article-title":"Environmental chemical exposures and mitochondrial dysfunction: a review of recent literature","volume":"9","author":"Reddam","year":"2022","journal-title":"Curr. Environ. Health Rep."},{"issue":"8","key":"10.1016\/j.mcn.2024.103981_bb1150","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s00415-019-09348-3","article-title":"Does the MDS-UPDRS provide the precision to assess progression in early Parkinson\u2019s disease? Learnings from the Parkinson\u2019s progression marker initiative cohort","volume":"266","author":"Regnault","year":"2019","journal-title":"J. Neurol."},{"key":"10.1016\/j.mcn.2024.103981_bb1155","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.602697","article-title":"Caffeine and Parkinson\u2019s disease: multiple benefits and emerging mechanisms","volume":"14","author":"Ren","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.mcn.2024.103981_bb1160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173914","article-title":"Assessment of the role of non-coding RNAs in the pathophysiology of Parkinson\u2019s disease","volume":"896","author":"Rezaei","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.mcn.2024.103981_bb1165","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.31557\/APJCP.2019.20.9.2707","article-title":"Genetic polymorphisms of xenobiotic metabolizing genes (GSTM1, GSTT1, GSTP1), gene-gene interaction with association to lung Cancer risk in North India; a case control study","volume":"20","author":"Ritambhara","year":"2019","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"7","key":"10.1016\/j.mcn.2024.103981_bb1170","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00394-011-0269-1","article-title":"Procyanidin B2 induces Nrf2 translocation and glutathione S-transferase P1 expression via ERKs and p38-MAPK pathways and protect human colonic cells against oxidative stress","volume":"51","author":"Rodriguez-Ramiro","year":"2012","journal-title":"Eur. J. Nutr."},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb1175","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.mcn.2008.06.007","article-title":"Functional interference between glycogen synthase kinase-3 beta and the transcription factor Nrf2 in protection against kainate-induced hippocampal cell death","volume":"39","author":"Rojo","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"issue":"7","key":"10.1016\/j.mcn.2024.103981_bb1180","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.717","article-title":"Influence of glutathione S-transferases (GSTM1, GSTT1, and GSTP1) genetic polymorphisms and smoking on susceptibility risk of chronic myeloid leukemia and treatment response","volume":"7","author":"Rostami","year":"2019","journal-title":"Mol. Genet. Genomic Med."},{"key":"10.1016\/j.mcn.2024.103981_bb1185","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102568","article-title":"The good Samaritan glutathione-S-transferase P1: an evolving relationship in nitric oxide metabolism mediated by the direct interactions between multiple effector molecules","volume":"59","author":"Russell","year":"2023","journal-title":"Redox Biol."},{"issue":"21","key":"10.1016\/j.mcn.2024.103981_bb1190","doi-asserted-by":"crossref","first-page":"14841","DOI":"10.1074\/jbc.M513737200","article-title":"Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2","volume":"281","author":"Salazar","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb1195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010712","article-title":"Role and dysregulation of miRNA in patients with Parkinson\u2019s disease","volume":"24","author":"Salemi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.mcn.2024.103981_bb1200","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1124\/pr.59.3.1","article-title":"Membrane prostaglandin E synthase-1: a novel therapeutic target","volume":"59","author":"Samuelsson","year":"2007","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.mcn.2024.103981_bb1205","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.neuropharm.2013.11.004","article-title":"NRF2-regulation in brain health and disease: implication of cerebral inflammation","volume":"79","author":"Sandberg","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.mcn.2024.103981_bb1210","doi-asserted-by":"crossref","first-page":"1185671","DOI":"10.3389\/fnagi.2023.1185671","article-title":"Physical activity and lifestyle modifications in the treatment of neurodegenerative diseases","volume":"15","author":"Santiago","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.mcn.2024.103981_bb1215","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/bs.irn.2019.10.014","article-title":"Corticobasal degeneration","volume":"149","author":"Saranza","year":"2019","journal-title":"Int. Rev. Neurobiol."},{"issue":"14","key":"10.1016\/j.mcn.2024.103981_bb1220","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21144996","article-title":"Protein degradation and the pathologic basis of phenylketonuria and hereditary Tyrosinemia","volume":"21","author":"Sarodaya","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.mcn.2024.103981_bb1225","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/bjc.2014.386","article-title":"Glutathione S-transferase P1 (GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell lines","volume":"111","author":"Sawers","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"22","key":"10.1016\/j.mcn.2024.103981_bb1230","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228637","article-title":"Efficacy of Sulforaphane in neurodegenerative diseases","volume":"21","author":"Schepici","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.mcn.2024.103981_bb1235","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1093\/cercor\/bhz280","article-title":"LRRK2 and GBA variants exert distinct influences on Parkinson\u2019s disease-specific metabolic networks","volume":"30","author":"Schindlbeck","year":"2020","journal-title":"Cereb. Cortex"},{"issue":"7","key":"10.1016\/j.mcn.2024.103981_bb1240","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/01.fpc.0000165725.81559.e3","article-title":"Characterization of the monomethylarsonate reductase and dehydroascorbate reductase activities of omega class glutathione transferase variants: implications for arsenic metabolism and the age-at-onset of Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"15","author":"Schmuck","year":"2005","journal-title":"Pharmacogenet. Genomics"},{"issue":"1\u20132","key":"10.1016\/j.mcn.2024.103981_bb1245","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jns.2012.10.024","article-title":"A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson\u2019s disease patients","volume":"324","author":"Schneider","year":"2013","journal-title":"J. Neurol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.mcn.2024.103981_bb1250","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jns.2015.06.028","article-title":"GM1 ganglioside in Parkinson\u2019s disease: pilot study of effects on dopamine transporter binding","volume":"356","author":"Schneider","year":"2015","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.mcn.2024.103981_bb1255","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1210\/er.2006-0050","article-title":"Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system","volume":"28","author":"Schumacher","year":"2007","journal-title":"Endocr. Rev."},{"issue":"16","key":"10.1016\/j.mcn.2024.103981_bb1260","first-page":"8537","article-title":"The role of GSTpi isoform in the cells signalling and anticancer therapy","volume":"24","author":"Sciskalska","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"6","key":"10.1016\/j.mcn.2024.103981_bb1265","doi-asserted-by":"crossref","first-page":"897","DOI":"10.4103\/1673-5374.208560","article-title":"On the role of endogenous neurotoxins and neuroprotection in Parkinson\u2019s disease","volume":"12","author":"Segura-Aguilar","year":"2017","journal-title":"Neural Regen. Res."},{"issue":"3","key":"10.1016\/j.mcn.2024.103981_bb1270","article-title":"A preclinical model for Parkinson\u2019s disease based on transcriptional gene activation via KEAP1\/NRF2 to develop new antioxidant therapies","volume":"12","author":"Segura-Aguilar","year":"2023","journal-title":"Antioxidants (Basel)"},{"issue":"2","key":"10.1016\/j.mcn.2024.103981_bb1275","article-title":"Neuroprotection against Aminochrome neurotoxicity: glutathione transferase M2-2 and DT-Diaphorase","volume":"11","author":"Segura-Aguilar","year":"2022","journal-title":"Antioxidants (Basel)"},{"issue":"2","key":"10.1016\/j.mcn.2024.103981_bb1280","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41409-023-02166-2","article-title":"Correction: effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan","volume":"59","author":"Seydoux","year":"2024","journal-title":"Bone Marrow Transplant."},{"issue":"4","key":"10.1016\/j.mcn.2024.103981_bb1285","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/ptr.3297","article-title":"Role of alpha class glutathione transferases (GSTs) in chemoprevention: GSTA1 and A4 overexpressing human leukemia (HL60) cells resist sulforaphane and curcumin induced toxicity","volume":"25","author":"Sharma","year":"2011","journal-title":"Phytother. Res."},{"issue":"5","key":"10.1016\/j.mcn.2024.103981_bb1290","doi-asserted-by":"crossref","first-page":"E131","DOI":"10.1038\/ncb0502-e131","article-title":"AP-1 as a regulator of cell life and death","volume":"4","author":"Shaulian","year":"2002","journal-title":"Nat. Cell Biol."},{"issue":"6","key":"10.1016\/j.mcn.2024.103981_bb1295","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s13318-017-0412-3","article-title":"Effect of long-term in vitro Lithium exposure on mRNA levels of Claudin-3, CYP1A1, ABCG2 and GSTM3 genes in the hCMEC\/D3 human brain endothelial cell line","volume":"42","author":"Shawahna","year":"2017","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb1300","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2353\/ajpath.2009.081019","article-title":"Identification of glutathione S-transferase pi as a protein involved in Parkinson disease progression","volume":"175","author":"Shi","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.mcn.2024.103981_bb1305","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3988\/jcn.2022.18.3.259","article-title":"Clinical aspects of the differential diagnosis of Parkinson\u2019s disease and parkinsonism","volume":"18","author":"Shin","year":"2022","journal-title":"J. Clin. Neurol."},{"issue":"3","key":"10.1016\/j.mcn.2024.103981_bb1310","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1124\/jpet.107.134593","article-title":"Age-dependent kinetics and metabolism of dichloroacetate: possible relevance to toxicity","volume":"324","author":"Shroads","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.mcn.2024.103981_bb1315","unstructured":"Siddiqi, T.F., P.A. Frankino, and A. Dillin, Tyrosine catabolites influence SKN-1 signaling in a model of type I Tyrosinemia. MicroPubl. Biol., 2022. 2022."},{"issue":"3","key":"10.1016\/j.mcn.2024.103981_bb1320","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1001\/jamaneurol.2020.4725","article-title":"Efficacy of Nilotinib in patients with moderately advanced Parkinson disease: a randomized clinical trial","volume":"78","author":"Simuni","year":"2021","journal-title":"JAMA Neurol."},{"issue":"1\u20132","key":"10.1016\/j.mcn.2024.103981_bb1325","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11010-008-9728-2","article-title":"Polymorphism in environment responsive genes and association with Parkinson disease","volume":"312","author":"Singh","year":"2008","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.mcn.2024.103981_bb1330","doi-asserted-by":"crossref","first-page":"9110","DOI":"10.1007\/s12035-024-04115-6","article-title":"HAT and HDAC: enzyme with contradictory action in neurodegenerative diseases","volume":"61","author":"Singh","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.mcn.2024.103981_bb1335","first-page":"5","volume":"10","author":"Singh","year":"2021","journal-title":"Glutathione S-Transferases in Cancer. Antioxidants (Basel)"},{"issue":"11","key":"10.1016\/j.mcn.2024.103981_bb1340","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.parkreldis.2014.08.019","article-title":"Early-onset Parkinson\u2019s disease due to PINK1 p.Q456X mutation--clinical and functional study","volume":"20","author":"Siuda","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"issue":"4","key":"10.1016\/j.mcn.2024.103981_bb1345","doi-asserted-by":"crossref","DOI":"10.3390\/cells13040296","article-title":"Pathogenesis of DJ-1\/PARK7-mediated Parkinson\u2019s disease","volume":"13","author":"Skou","year":"2024","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.mcn.2024.103981_bb1350","doi-asserted-by":"crossref","DOI":"10.3390\/cells11081261","article-title":"GBA variants and Parkinson disease: mechanisms and treatments","volume":"11","author":"Smith","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.mcn.2024.103981_bb1355","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.971252","article-title":"Genetic variations in GBA1 and LRRK2 genes: biochemical and clinical consequences in Parkinson disease","volume":"13","author":"Smith","year":"2022","journal-title":"Front. Neurol."},{"issue":"11","key":"10.1016\/j.mcn.2024.103981_bb1360","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/mds.23148","article-title":"A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson\u2019s disease","volume":"25","author":"Snow","year":"2010","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb1365","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010107","article-title":"Neuroprotective effects of coffee bioactive compounds: a review","volume":"22","author":"Socala","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mcn.2024.103981_bb1370","doi-asserted-by":"crossref","DOI":"10.1016\/j.heares.2020.108002","article-title":"Cochlear detoxification: role of alpha class glutathione transferases in protection against oxidative lipid damage, ototoxicity, and cochlear aging","volume":"402","author":"Someya","year":"2021","journal-title":"Hear. Res."},{"key":"10.1016\/j.mcn.2024.103981_bb1375","doi-asserted-by":"crossref","first-page":"1123621","DOI":"10.3389\/fcell.2023.1123621","article-title":"Epigenetic modification in Parkinson\u2019s disease","volume":"11","author":"Song","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.mcn.2024.103981_bb1380","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/00008571-200008000-00009","article-title":"Characterization of the glutathione S-transferase GSTT1 deletion: discrimination of all genotypes by polymerase chain reaction indicates a trimodular genotype-phenotype correlation","volume":"10","author":"Sprenger","year":"2000","journal-title":"Pharmacogenetics"},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb1385","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1073\/pnas.89.1.444","article-title":"S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds","volume":"89","author":"Stamler","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.mcn.2024.103981_bb1390","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/WCO.0000000000001285","article-title":"An update on multiple system atrophy","volume":"37","author":"Stankovic","year":"2024","journal-title":"Curr. Opin. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.mcn.2024.103981_bb1395","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0014-5793(91)81174-7","article-title":"Mutation of an evolutionarily conserved tyrosine residue in the active site of a human class alpha glutathione transferase","volume":"293","author":"Stenberg","year":"1991","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.mcn.2024.103981_bb1400","first-page":"141","article-title":"Determination of glutathione S-transferase mu and theta polymorphisms in neurological disease","volume":"18","author":"Stroombergen","year":"1999","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.mcn.2024.103981_bb1405","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103116","article-title":"GSTP alleviates acute lung injury by S-glutathionylation of KEAP1 and subsequent activation of NRF2 pathway","volume":"71","author":"Sun","year":"2024","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.mcn.2024.103981_bb1410","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1471-4159.2009.06487.x","article-title":"Up-regulation of the type 3 ryanodine receptor is neuroprotective in the TgCRND8 mouse model of Alzheimer\u2019s disease","volume":"112","author":"Supnet","year":"2010","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.mcn.2024.103981_bb1415","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.31557\/APJCP.2022.23.8.2655","article-title":"Genomic pattern of GSTM1 and T1 gene null polymorphism of head and neck Cancer patients in eastern India","volume":"23","author":"Surit","year":"2022","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"6","key":"10.1016\/j.mcn.2024.103981_bb1420","doi-asserted-by":"crossref","DOI":"10.3390\/ph15060692","article-title":"A pivotal role of Nrf2 in neurodegenerative disorders: a new way for therapeutic strategies","volume":"15","author":"Suzen","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.mcn.2024.103981_bb1425","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fonc.2017.00085","article-title":"The KEAP1-NRF2 system in Cancer","volume":"7","author":"Taguchi","year":"2017","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.mcn.2024.103981_bb1430","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1289\/ehp.1002839","article-title":"Rotenone, paraquat, and Parkinson\u2019s disease","volume":"119","author":"Tanner","year":"2011","journal-title":"Environ. Health Perspect."},{"issue":"9","key":"10.1016\/j.mcn.2024.103981_bb1435","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.bcp.2006.09.027","article-title":"Redox in redux: emergent roles for glutathione S-transferase P (GSTP) in regulation of cell signaling and S-glutathionylation","volume":"73","author":"Tew","year":"2007","journal-title":"Biochem. Pharmacol."},{"issue":"12","key":"10.1016\/j.mcn.2024.103981_bb1440","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1089\/ars.2012.4640","article-title":"Glutathione-s-transferases as determinants of cell survival and death","volume":"17","author":"Tew","year":"2012","journal-title":"Antioxid. Redox Signal."},{"issue":"8","key":"10.1016\/j.mcn.2024.103981_bb1445","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci13081202","article-title":"Neurological insights into sleep disorders in Parkinson\u2019s disease","volume":"13","author":"Thangaleela","year":"2023","journal-title":"Brain Sci."},{"issue":"6","key":"10.1016\/j.mcn.2024.103981_bb1450","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2165\/11533130-000000000-00000","article-title":"Juvenile parkinsonism: epidemiology, diagnosis and treatment","volume":"24","author":"Thomsen","year":"2010","journal-title":"CNS Drugs"},{"issue":"6","key":"10.1016\/j.mcn.2024.103981_bb1455","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.526","article-title":"GSTZ1 genotypes correlate with dichloroacetate pharmacokinetics and chronic side effects in multiple myeloma patients in a pilot phase 2 clinical trial","volume":"7","author":"Tian","year":"2019","journal-title":"Pharmacol. Res. Perspect."},{"issue":"2","key":"10.1016\/j.mcn.2024.103981_bb1460","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41582-019-0301-2","article-title":"LRRK2 in Parkinson disease: challenges of clinical trials","volume":"16","author":"Tolosa","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.mcn.2024.103981_bb1465","first-page":"4709322","article-title":"Mercury and Parkinson\u2019s disease: promising leads, but research is needed","volume":"2023","author":"Torrey","year":"2023","journal-title":"Parkinsons Dis."},{"issue":"3\u20134","key":"10.1016\/j.mcn.2024.103981_bb1470","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0753-3322(03)00043-X","article-title":"The importance of glutathione in human disease","volume":"57","author":"Townsend","year":"2003","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.mcn.2024.103981_bb1475","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3233\/JPD-202406","article-title":"Whole clinic research enrollment in Parkinson\u2019s disease: the molecular integration in neurological diagnosis (MIND) study","volume":"11","author":"Tropea","year":"2021","journal-title":"J. Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb1480","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41531-023-00568-z","article-title":"Linking environmental risk factors with epigenetic mechanisms in Parkinson's disease","volume":"9","author":"Tsalenchuk","year":"2023","journal-title":"NPJ Parkinsons Dis."},{"issue":"17","key":"10.1016\/j.mcn.2024.103981_bb1485","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1093\/hmg\/ddu178","article-title":"Parkinson\u2019s disease-linked mutations in VPS35 induce dopaminergic neurodegeneration","volume":"23","author":"Tsika","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mcn.2024.103981_bb1490","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.toxrep.2021.03.009","article-title":"Metal elements and pesticides as risk factors for Parkinson\u2019s disease - a review","volume":"8","author":"Ullah","year":"2021","journal-title":"Toxicol. Rep."},{"issue":"3","key":"10.1016\/j.mcn.2024.103981_bb1495","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1080\/07391102.2020.1827036","article-title":"In silico and in vitro investigations on the protein-protein interactions of glutathione S-transferases with mitogen-activated protein kinase 8 and apoptosis signal-regulating kinase 1","volume":"40","author":"Uppugunduri","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"2","key":"10.1016\/j.mcn.2024.103981_bb1500","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s12640-020-00327-5","article-title":"Cellular trafficking of glutathione transferase M2-2 between U373MG and SHSY-S7 cells is mediated by exosomes","volume":"39","author":"Valdes","year":"2021","journal-title":"Neurotox. Res."},{"issue":"11","key":"10.1016\/j.mcn.2024.103981_bb1505","doi-asserted-by":"crossref","first-page":"5798","DOI":"10.1007\/s00415-022-11282-w","article-title":"Influence of heavy metals in Parkinson\u2019s disease: an overview","volume":"269","author":"Vellingiri","year":"2022","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.mcn.2024.103981_bb1510","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1468-1331.2006.01590.x","article-title":"Association of A313 G polymorphism (GSTP1*B) in the glutathione-S-transferase P1 gene with sporadic Parkinson\u2019s disease","volume":"14","author":"Vilar","year":"2007","journal-title":"Eur. J. Neurol."},{"issue":"9","key":"10.1016\/j.mcn.2024.103981_bb1515","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/leu.2008.169","article-title":"Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia","volume":"22","author":"Voso","year":"2008","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.mcn.2024.103981_bb1520","doi-asserted-by":"crossref","first-page":"7423","DOI":"10.1007\/s11033-014-3631-6","article-title":"Null genotype of GSTT1 contributes to increased Parkinson\u2019s disease risk in Caucasians: evidence from a meta-analysis","volume":"41","author":"Wang","year":"2014","journal-title":"Mol. Biol. Rep."},{"issue":"2","key":"10.1016\/j.mcn.2024.103981_bb1525","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1080\/01616412.2015.1126996","article-title":"Glutathione S-transferase M1 polymorphisms and Parkinson\u2019s disease risk: a meta-analysis","volume":"38","author":"Wang","year":"2016","journal-title":"Neurol. Res."},{"issue":"5","key":"10.1016\/j.mcn.2024.103981_bb1530","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41419-021-03718-4","article-title":"GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2\/GPX4 axis","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1\u20132","key":"10.1016\/j.mcn.2024.103981_bb1535","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jns.2013.12.018","article-title":"Association between glutathione S-transferase M1\/glutathione S-transferase T1 polymorphisms and Parkinson\u2019s disease: a meta-analysis","volume":"338","author":"Wang","year":"2014","journal-title":"J. Neurol. Sci."},{"issue":"24","key":"10.1016\/j.mcn.2024.103981_bb1540","doi-asserted-by":"crossref","first-page":"20999","DOI":"10.1074\/jbc.M101355200","article-title":"Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus","volume":"276","author":"Wang","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.mcn.2024.103981_bb1545","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.molmed.2022.02.003","article-title":"Ferroptosis in Parkinson\u2019s disease: glia-neuron crosstalk","volume":"28","author":"Wang","year":"2022","journal-title":"Trends Mol. Med."},{"issue":"4","key":"10.1016\/j.mcn.2024.103981_bb1550","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25042009","article-title":"Parkinson\u2019s disease: cells succumbing to lifelong dopamine-related oxidative stress and other bioenergetic challenges","volume":"25","author":"Watanabe","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb1555","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1515\/med-2016-0094","article-title":"A meta-analysis of association between glutathione S-transferase M1 gene polymorphism and Parkinson's disease susceptibility","volume":"11","author":"Weikang","year":"2016","journal-title":"Open Med. (Wars)"},{"issue":"2","key":"10.1016\/j.mcn.2024.103981_bb1560","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/mds.28874","article-title":"Relationship of genotype, phenotype, and treatment in Dopa-responsive dystonia: MDSGene review","volume":"37","author":"Weissbach","year":"2022","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.mcn.2024.103981_bb1565","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/mds.25247","article-title":"Cumulative exposure to lead and cognition in persons with Parkinson\u2019s disease","volume":"28","author":"Weuve","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.mcn.2024.103981_bb1570","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0076-6879(05)01005-0","article-title":"Characterization of the omega class of glutathione transferases","volume":"401","author":"Whitbread","year":"2005","journal-title":"Methods Enzymol."},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb1575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-4838(94)90086-8","article-title":"Structure and function of glutathione S-transferases","volume":"1205","author":"Wilce","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mcn.2024.103981_bb1580","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108025","article-title":"Nilotinib inhibits microglia-mediated neuroinflammation to protect against dopaminergic neuronal death in Parkinson\u2019s disease models","volume":"99","author":"Wu","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb1585","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1089\/ars.2010.3540","article-title":"S-glutathionylation: from molecular mechanisms to health outcomes","volume":"15","author":"Xiong","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.mcn.2024.103981_bb1590","first-page":"1720621","article-title":"Alpha-Synuclein in Parkinson\u2019s disease: from Pathogenetic dysfunction to potential clinical application","volume":"2016","author":"Xu","year":"2016","journal-title":"Parkinsons Dis."},{"issue":"10","key":"10.1016\/j.mcn.2024.103981_bb1595","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s11910-022-01223-5","article-title":"Longitudinal studies of sleep disturbances in Parkinson\u2019s disease","volume":"22","author":"Xu","year":"2022","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"15","key":"10.1016\/j.mcn.2024.103981_bb1600","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019101964","article-title":"GSTZ1-1 deficiency activates NRF2\/IGF1R Axis in HCC via accumulation of Oncometabolite Succinylacetone","volume":"38","author":"Yang","year":"2019","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb1605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2012.10.033","article-title":"MAP kinase signalling cascades and transcriptional regulation","volume":"513","author":"Yang","year":"2013","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.mcn.2024.103981_bb1610","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","article-title":"Ferroptosis: death by lipid peroxidation","volume":"26","author":"Yang","year":"2016","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.mcn.2024.103981_bb1615","article-title":"Role of Nrf2 in Parkinson\u2019s disease: toward new perspectives","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.mcn.2024.103981_bb1620","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030091","article-title":"Five glutathione s-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies","volume":"3","author":"Ye","year":"2006","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb1625","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41531-023-00486-0","article-title":"Association between smoking and all-cause mortality in Parkinson's disease","volume":"9","author":"Yoon","year":"2023","journal-title":"NPJ Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb1630","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12031-013-0207-1","article-title":"PINK1 and its familial Parkinson\u2019s disease-associated mutation regulate brain vascular endothelial inflammation","volume":"53","author":"Yunfu","year":"2014","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.mcn.2024.103981_bb1635","series-title":"Parkinson Disease, in StatPearls","author":"Zafar","year":"2024"},{"issue":"6","key":"10.1016\/j.mcn.2024.103981_bb1640","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.1007\/s11033-023-08409-1","article-title":"Targeting Nrf2 signaling pathway and oxidative stress by resveratrol for Parkinson\u2019s disease: an overview and update on new developments","volume":"50","author":"Zamanian","year":"2023","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.mcn.2024.103981_bb1645","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1124\/jpet.120.000417","article-title":"Glutathione S-transferase P influences redox homeostasis and response to drugs that induce the unfolded protein response in zebrafish","volume":"377","author":"Zhang","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.mcn.2024.103981_bb1650","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2353\/ajpath.2007.070472","article-title":"Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein mediate cerebral ischemia-induced nuclear factor-kappaB pathway activation","volume":"171","author":"Zhang","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mcn.2024.103981_bb1655","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3389\/fnmol.2018.00391","article-title":"A comprehensive analysis of the association between SNCA polymorphisms and the risk of Parkinson\u2019s disease","volume":"11","author":"Zhang","year":"2018","journal-title":"Front. Mol. Neurosci."},{"issue":"17","key":"10.1016\/j.mcn.2024.103981_bb1660","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.259724","article-title":"Leucine-rich repeat kinase 2 at a glance","volume":"136","author":"Zhu","year":"2023","journal-title":"J. Cell Sci."},{"issue":"3","key":"10.1016\/j.mcn.2024.103981_bb1665","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1021\/acscentsci.7b00028","article-title":"On the mechanism of Cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the role of lipid peroxidation in Ferroptotic cell death","volume":"3","author":"Zilka","year":"2017","journal-title":"ACS Cent. Sci."}],"container-title":["Molecular and Cellular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743124000666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743124000666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T03:36:14Z","timestamp":1741664174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044743124000666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":333,"alternative-id":["S1044743124000666"],"URL":"https:\/\/doi.org\/10.1016\/j.mcn.2024.103981","relation":{},"ISSN":["1044-7431"],"issn-type":[{"value":"1044-7431","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glutathione S-transferase: A keystone in Parkinson's disease pathogenesis and therapy","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcn.2024.103981","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103981"}}